BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET

PR Newswire

SAN RAFAEL, Calif., July 22, 2025

SAN RAFAEL, Calif. , July 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy , President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, August 4, 2025 , at 4:30 p.m. ET to discuss second quarter 2025 financial results and provide a general business update.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

Dial-in Number
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 6336054 

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 6336054

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,  https://investors.biomarin.com/ . A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California -based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com

Contacts:


Investors

Media

Traci McCarty 

Marni Kottle

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(650) 374-2803

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2025-financial-results-conference-call-and-webcast-on-monday-august-4-2025-at-430pm-et-302510004.html

SOURCE BioMarin Pharmaceutical Inc.

Läs mer på PR Newswire

Ämnen i artikeln

BioMarin Pharmaceutical

Senast

59,67

1 dag %

0,79%

1 dag

1 mån

1 år

Rapportperioden

Marknadsöversikt

OMX Stockholm 30

1 DAG %

0,30%

Senast

2 600,22

1 mån
Loading market data...
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.